Statistics for The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: A Turkish oncology group study
Total visits
| views | |
|---|---|
| The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: A Turkish oncology group study | 4 |
Total visits per month
| views | |
|---|---|
| June 2024 | 3 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 1 |
| November 2024 | 0 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| Caner_2022.pdf | 9 |
Top country views
| views | |
|---|---|
| Turkey | 1 |
Top city views
| views | |
|---|---|
| Ankara | 1 |